{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:40Z","timestamp":1793196580544,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011194","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000}}],"reference-count":111,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011194.pub2","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T23:34:41Z","timestamp":1488929681000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Proton pump inhibitors for functional dyspepsia"],"prefix":"10.1002","author":[{"given":"Maria Ines","family":"Pinto-Sanchez","sequence":"first","affiliation":[{"name":"McMaster University; Department of Medicine, Division of Gastroenterology; Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yuan","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Medicine, Division of Gastroenterology; Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premysl","family":"Bercik","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Medicine, Division of Gastroenterology; Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Medicine, Division of Gastroenterology; Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,8]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gut.47.4.473","article-title":"Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group","volume":"47","author":"Blum","year":"2000","journal-title":"Gut"},{"issue":"12","key":"10.1002\/14651858.CD011194.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/003655202762671260","article-title":"Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial","volume":"37","author":"Bolling-Sternevald","year":"2002","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"Suppl VI","key":"10.1002\/14651858.CD011194.pub2-BIB0003|cit3","first-page":"A285","article-title":"A comparison of lansoprazole vs ranitidine in the treatment of functional ulcer-like dyspepsia as defined by the Rome II criteria","volume":"53","author":"Dillon","year":"2004","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD011194.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/003655299750026029","article-title":"Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern","volume":"34","author":"Farup","year":"1999","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/gut.2010.228064","article-title":"BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy","volume":"60","author":"Fletcher","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.dld.2004.09.021","article-title":"A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia","volume":"37","author":"Gerson","year":"2005","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0007|cit7","first-page":"A89","article-title":"Therapeutic efficacy of 15mg lansoprazole mane in 269 patients suffering from non-ulcer dyspepsia (NUD): a multicentre, randomised, double-blind study","volume":"43 (Suppl 2)","author":"Hengels","year":"1998","journal-title":"Gut"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00535-010-0334-1","article-title":"Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?","volume":"46","author":"Hsu","year":"2011","journal-title":"Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD011194.pub2-BIB0009|cit9","first-page":"547","article-title":"Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan","volume":"16","author":"Iwakiri","year":"2013","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD011194.pub2-BIB0010|cit10","first-page":"254","article-title":"Comparison of mosapride and pantoprazole in treating functional dyspepsia","volume":"16","author":"Jiang","year":"2011","journal-title":"Chinese Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5056\/jnm15178","article-title":"Efficacy of DA-9701 (Motilitone) in functional dyspepsia compared to pantoprazole: a multicenter, randomized, double-blind, non-inferiority study","volume":"22","author":"Jung","year":"2016","journal-title":"Journal of Neurogastroenterology and Motility"},{"issue":"5","key":"10.1002\/14651858.CD011194.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(11)60761-0","article-title":"A multicenter open-label randomized trial comparing rabeprazole versus itopride in Japanese functional dyspepsia: the NAGOYA Study","volume":"140","author":"Kamiya","year":"2011","journal-title":"Gastroenterology"},{"issue":"5 (Suppl 1)","key":"10.1002\/14651858.CD011194.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"A468","DOI":"10.1016\/S0016-5085(12)61775-2","article-title":"Are there any differences among predictive response factors for a proton pump inhibitor and prokinetics? Sub-analysis of a multicenter open-label randomized trial comparing rabeprazole versus itopride in Japanese functional dyspepsia: the NAGOYA study","volume":"142","author":"Kamiya","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0014|cit14","first-page":"337","article-title":"Low-dose omeprazole treatment of functional dyspepsia","volume":"6","author":"Li","year":"2003","journal-title":"Chinese Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD011194.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.amjmed.2004.01.008","article-title":"Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials","volume":"116","author":"Peura","year":"2004","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011194.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/2050640613510904","article-title":"Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): a multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial","volume":"1","author":"Suzuki","year":"2013","journal-title":"United European Gastroenterology Journal"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the BOND and OPERA studies)","volume":"12","author":"Talley","year":"1998","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the BOND and OPERA studies)","volume":"12","author":"Talley","year":"1998","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2036.2007.03410.x","article-title":"Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?","volume":"26","author":"Talley","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD011194.pub2-BIB0020|cit20","first-page":"S55","article-title":"Rabeprazole improves the symptoms of functional dyspepsia - a double blind randomized placebo-controlled multi-center trial in Japan: the CAESAR Study","volume":"138","author":"Tominaga","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD011194.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1185\/03007990802184545","article-title":"Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia","volume":"24","author":"Rensburg","year":"2008","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/j.1572-0241.2006.00751.x","article-title":"Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled \"ENTER\" trial","volume":"101","author":"Zanten","year":"2006","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gut.51.4.502","article-title":"Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients","volume":"51","author":"Wong","year":"2002","journal-title":"Gut"},{"issue":"29","key":"10.1002\/14651858.CD011194.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.11569\/wcjd.v22.i29.4514","article-title":"Efficacy and safety of pantoprazole sodium enteric coated tablets combined with mosapride in treatment of functional dyspepsia","volume":"22","author":"Yang","year":"2014","journal-title":"World Chinese Journal of Digestology"},{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S888","DOI":"10.1016\/S0016-5085(15)33016-X","article-title":"Is proton pump inhibitor use associated with delayed gastric emptying in functional dyspepsia subjects?","volume":"148","author":"Almazar","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD011194.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2036.2003.01651.x","article-title":"Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?","volume":"18","author":"Bolling-Sternevald","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0027|cit27","first-page":"122","article-title":"Effectiveness of Ultop 10 mg using at treatment of functional (nonulcer) dyspepsia syndrome","volume":"6","author":"Burkov","year":"2009","journal-title":"Eksperimental'naia i Klinicheskaia Gastroenterologiia [Experimental & Clinical Gastroenterology]"},{"issue":"11","key":"10.1002\/14651858.CD011194.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1046\/j.1365-2036.2000.00866.x","article-title":"Identifying responders to acid suppression in dyspepsia using a random starting day trial","volume":"14","author":"Bytzer","year":"2000","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD011194.pub2-BIB0029|cit29","first-page":"S679","article-title":"The effect of proton pump inhibitor (PPI) on plasma 5-hydroxytryptamine (5-HT) levels in patients with functional dyspepsia (FD): a double-blind randomized control trial","volume":"144","author":"Cheung","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1590-8658(01)80066-9","article-title":"Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia","volume":"33","author":"Chuang","year":"2001","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39479.640486.AE","article-title":"Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial)","volume":"336","author":"Delaney","year":"2008","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD011194.pub2-BIB0032|cit32","first-page":"1592","article-title":"Treatment of functional dyspepsia by Chinese medical syndrome typing: a randomized control research","volume":"32","author":"Fan","year":"2012","journal-title":"Zhongguo Zhong Xi Yi Jie He za Zhi [Chinese Journal of Integrated Traditional and Western Medicine]"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13814788.2012.665443","article-title":"Patient adherence to prescribed medication instructions for dyspepsia: the DIAMOND study","volume":"18","author":"Fransen","year":"2012","journal-title":"European Journal of General Practice"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2036.1998.0284f.x","article-title":"First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid\/alginate liquid: a multicentre study in general practice","volume":"12","author":"Goves","year":"1998","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD011194.pub2-BIB0035|cit35","first-page":"1071","article-title":"Long-term efficacy and safety research on functional dyspepsia treated with electroacupuncture and Zhizhu Kuanzhong capsule","volume":"31","author":"Guo","year":"2011","journal-title":"Zhongguo Zhen Jiu [Chinese Acupuncture & Moxibustion]"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0036|cit36","first-page":"35","article-title":"Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type","volume":"101","author":"Ivanova","year":"2002","journal-title":"Eksperimental'naia i Klinicheskaia Gastroenterologiia [Experimental & Clinical Gastroenterology]"},{"issue":"3","key":"10.1002\/14651858.CD011194.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2036.1997.00179.x","article-title":"Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice","volume":"11","author":"Jones","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD011194.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2036.1999.00455.x","article-title":"Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia","volume":"13","author":"Jones","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD011194.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5009\/gnl.2013.7.1.16","article-title":"A study on the efficacy of proton pump inhibitors in Helicobacter pylori-negative primary care patients with dyspepsia in Japan","volume":"7","author":"Kamada","year":"2013","journal-title":"Gut and Liver"},{"issue":"5 (suppl 1)","key":"10.1002\/14651858.CD011194.pub2-BIB0040|cit40","first-page":"S","article-title":"Are there any differences among predictive response factors for a proton pump inhibitor and prokinetics? Sub-analysis of a multicenter open-label randomized trial comparing rabeprazole versus itopride in Japanese functional dyspepsia: the NAGOYA study","volume":"142","author":"Kamiya","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD011194.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1572-0241.2007.01229.x","article-title":"Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: a randomized controlled trial with 12-month follow-up","volume":"102","author":"Leung","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"469","key":"10.1002\/14651858.CD011194.pub2-BIB0042|cit42","first-page":"619","article-title":"A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome","volume":"51","author":"Lewin van den Broek","year":"2001","journal-title":"British Journal of General Practice"},{"issue":"3","key":"10.1002\/14651858.CD011194.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2036.2004.02072.x","article-title":"Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design","volume":"20","author":"Madsen","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD011194.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000121353","article-title":"Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model","volume":"26","author":"Madsen","year":"2008","journal-title":"Digestive Diseases (Basel, Switzerland)"},{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0045|cit45","first-page":"263","article-title":"Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)","volume":"26","author":"Mazure","year":"1996","journal-title":"Acta Gastroenterologica Latinoamericana"},{"issue":"6","key":"10.1002\/14651858.CD011194.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/003655299750026010","article-title":"Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study","volume":"34","author":"Meineche-Schmidt","year":"1999","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD011194.pub2-BIB0047|cit47","first-page":"2777","article-title":"Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial","volume":"95","author":"Meineche-Schmidt","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD011194.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2036.2004.02243.x","article-title":"Classification of dyspepsia and response to treatment with proton-pump inhibitors","volume":"20","author":"Meineche-Schmidt","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD011194.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/jgh.12877","article-title":"Demography and treatment response in patients with predominant non-erosive reflux disease or functional dyspepsia","volume":"30","author":"Miwa","year":"2015","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"37","key":"10.1002\/14651858.CD011194.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1055\/s-0029-1237519","article-title":"Irritable bowel disease with flatulence: is the breath test for carbohydrate malabsorption obligatory?","volume":"134","author":"M\u00f6nnikes","year":"2009","journal-title":"Deutsche Medizinische Wochenschrift (1946)"},{"issue":"11","key":"10.1002\/14651858.CD011194.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2036.2012.05085.x","article-title":"Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease","volume":"35","author":"M\u00f6nnikes","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jgh.12744","article-title":"Pretreatment prediction of symptom response to proton pump inhibitor therapy","volume":"Suppl 1","author":"Nagahara","year":"2015","journal-title":"Gastroenterology & Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD011194.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0895-4356(00)00365-6","article-title":"SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health","volume":"54","author":"Rabeneck","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD011194.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/MEG.0b013e32833d56d1","article-title":"Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse","volume":"22","author":"Reimer","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD011194.pub2-BIB0055|cit55","first-page":"S891","article-title":"Randomized clinical study on functional dyspepsia treatment with herbal preparation puyuanhewei and therapeutic response evaluation by endomicroscopy","volume":"148","author":"Rui","year":"2015","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1002\/14651858.CD011194.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3748\/wjg.v18.i13.1517","article-title":"Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia","volume":"18","author":"Sakaguchi","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-230X-12-42","article-title":"Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)","volume":"12","author":"Sakurai","year":"2012","journal-title":"BMC Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD011194.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1046\/j.1365-2036.2001.01123.x","article-title":"Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia","volume":"15","author":"Schwartz","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0059|cit59","first-page":"A343","article-title":"A lyophilized form of S. boulardii enhances the effect of omeprazole-triple therapy in patients with organic or functional dyspepsia","volume":"Suppl 1","author":"Theodoropoulos","year":"2009","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD011194.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1365-2036.2007.03271.x","article-title":"Symptom overlap in patients with upper gastrointestinal complaints in the Canadian Confirmatory Acid Suppression Test (CAST) study: further psychometric validation of the reflux disease questionnaire","volume":"25","author":"Zanten","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD011194.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1572-0241.2005.40280.x","article-title":"A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study","volume":"100","author":"Veldhuyzen van Zanten","year":"2005","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011194.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00228-007-0287-3","article-title":"Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study","volume":"63","author":"Zeng","year":"2007","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"s4","key":"10.1002\/14651858.CD011194.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1440-1746.2011.06826.x","article-title":"A preliminary analysis of the effect Iberogast, Nexium, dual Iberogast + Nexium or dual placebo on symptoms in patients with functional dyspepsia","volume":"26","author":"Pilichiewicz","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0064|cit64","unstructured":"From the Biomedical to the Biopsychosocial Model, From Theory to Practice. Ongoing study March 2009."},{"issue":"6","key":"10.1002\/14651858.CD011194.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2036.2004.01878.x","article-title":"Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia","volume":"19","author":"Abraham","year":"2004","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0194599816648298","article-title":"Adverse event reporting for proton pump inhibitor therapy: an overview of systematic reviews","volume":"155","author":"Abramowitz","year":"2016","journal-title":"Otolaryngology and Head and Neck Surgery"},{"issue":"8","key":"10.1002\/14651858.CD011194.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/BF02212683","article-title":"Nutrient specific modulation of gastric mechanosensitivity in patients with functional dyspepsia","volume":"40","author":"Barbera","year":"1995","journal-title":"Digestive Diseases and Sciences"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011194.pub2-BIB0068|cit68","first-page":"30","article-title":"Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying","volume":"55","author":"Bekhti","year":"1979","journal-title":"Postgraduate Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1572-0241.2000.01983.x","article-title":"The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection","volume":"95","author":"Berc\u00edk","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"26","key":"10.1002\/14651858.CD011194.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJM199812243392602","article-title":"Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus clarithromycin and amoxicillin effect one year after treatment (OCAY) study group","volume":"339","author":"Blum","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011194.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2036.2003.01651.x","article-title":"Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?","volume":"18","author":"Bolling-Sternevald","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD011194.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.37071","article-title":"Long-term improvement in functional dyspepsia using hypnotherapy","volume":"123","author":"Calvert","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011194.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrgastro.2013.11","article-title":"Current management strategies and emerging treatments for functional\u00a0dyspepsia","volume":"10","author":"Camillieri","year":"2013","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD011194.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2036.2000.00801.x","article-title":"Cisapride provides symptomatic relief in functional dyspepsia associated with gastric myoelectrical abnormality","volume":"14","author":"Chen","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"8585","key":"10.1002\/14651858.CD011194.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(88)91364-5","article-title":"Management of dyspepsia: report of a working party","volume":"331","author":"Colin-Jones","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0076|cit76","first-page":"ii","article-title":"Rome II: a multinational consensus document on functional gastrointestinal disorders - functional bowel disorders and functional abdominal pain","volume":"45","author":"Drossman","year":"1999","journal-title":"Gut"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD011194.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/j.1572-0241.2001.04037.x","article-title":"Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia","volume":"96","author":"Froehlich","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0079|cit79","unstructured":"Brozek J, Oxman A, Sch\u00fcnemann H GRADEpro 2008"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0080|cit80","unstructured":"GraphPad Software GraphPad Software 2010"},{"issue":"3","key":"10.1002\/14651858.CD011194.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","article-title":"A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia","volume":"119","author":"Hamilton","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011194.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1572-0241.1998.00368.x","article-title":"Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia","volume":"93","author":"Hansen","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0083|cit83","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"9","key":"10.1002\/14651858.CD011194.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1046\/j.1365-2036.2002.01322.x","article-title":"A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia","volume":"16","author":"Holtmann","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD011194.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cgh.2012.11.031","article-title":"Reported side effects and complications of long-term proton pump inhibitor use","volume":"11","author":"Johnson","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011194.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijcard.2012.03.085","article-title":"No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis","volume":"167","author":"Kwok\u00a0CS","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD011194.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2012.05128.x","article-title":"Review article: current treatment options and management of functional dyspepsia","volume":"36","author":"Lacy\u00a0BE","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/apt.12355","article-title":"Functional dyspepsia: the economic impact to patients","volume":"38","author":"Lacy","year":"2013","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"26","key":"10.1002\/14651858.CD011194.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199812243392601","article-title":"Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia","volume":"339","author":"McColl","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011194.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001960","article-title":"Pharmacological interventions for non-ulcer dyspepsia","author":"Moayyedi","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001960.pub3","article-title":"Pharmacological interventions for non-ulcer dyspepsia","author":"Moayyedi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001960.pub4","article-title":"Pharmacological interventions for non-ulcer dyspepsia","author":"Moayyedi","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.mcna.2014.01.007","article-title":"Dyspepsia","volume":"98","author":"Overland","year":"2014","journal-title":"Medical Clinics of North America"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0094|cit94","unstructured":"Thomson ISI ResearchSoft Reference Manager 2014"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0095|cit95","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD011194.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2004.02160.x","article-title":"Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors - overview and clinical implications","volume":"20","author":"Robinson","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","article-title":"The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal","volume":"37","author":"Savarino","year":"2017","journal-title":"European Journal of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011194.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe proton pump inhibitor therapy in acid-related diseases - a position paper addressing benefits and potential harms of acid suppression","volume":"14","author":"Scarpignato","year":"2016","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1756283X11398735","article-title":"Proton pump inhibitors for the treatment of functional dyspepsia","volume":"4","author":"Suzuki","year":"2011","journal-title":"Therapeutic Advances in Gastroenterology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0101|cit101","first-page":"47","article-title":"Drug treatment of functional dyspepsia","volume":"182","author":"Talley","year":"1991","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.1995.tb00359.x","article-title":"Functional dyspepsia - should treatment be targeted on disturbed physiology?","volume":"9","author":"Talley","year":"1995","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"7187","key":"10.1002\/14651858.CD011194.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.318.7187.833","article-title":"Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months\u2019 follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group","volume":"318","author":"Talley\u00a0NJ","year":"1999","journal-title":"BMJ"},{"issue":"15","key":"10.1002\/14651858.CD011194.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199910073411502","article-title":"Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia","volume":"341","author":"Talley\u00a0NJ","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011194.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MOG.0000000000000306","article-title":"Functional dyspepsia","volume":"32","author":"Talley","year":"2016","journal-title":"Current Opinions in Gastroenterology"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0106|cit106","doi-asserted-by":"crossref","unstructured":"Tett\u00a0SE \u00a0Sketris I \u00a0Cooke C \u00a0van Zanten SV \u00a0Barozzi N Differences in utilization of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada Pharmacoepidemiology and Drug Safety 2013 735 43 10.1002\/pds.3442","DOI":"10.1002\/pds.3442"},{"key":"10.1002\/14651858.CD011194.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00365529309098328","article-title":"Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study","volume":"195","author":"Outryve","year":"1993","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011194.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.37.6.743","article-title":"Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole","volume":"37","author":"Verd\u00fa","year":"1995","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD011194.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cgh.2006.09.012","article-title":"Effects of proton pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials","volume":"5","author":"Wang","year":"2007","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/17512433.2013.811206","article-title":"Perils and pitfalls of long-term effects of proton pump inhibitors","volume":"6","author":"Wilhelm","year":"2013","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD011194.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.gastro.2010.08.023","article-title":"Safety of proton pump inhibitor exposure","volume":"139","author":"Yang","year":"2010","journal-title":"Gastroenterology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011194.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011194.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:53:27Z","timestamp":1628535207000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011194.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,8]]},"references-count":111,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011194.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727380495.793536945","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,8]]}}}